TRPM2 can directly activate PKCα by regulating Ca2+ levels in PC cells and indirectly activate PKCε and PKCδ by controlling diacylglycerol (DAG) levels, which in turn affects the downstream MAPK/MEK pathway to promote PC growth [25]. Here, PRKCD is linked to pachyonychia congenita.